Arrowhead Pharmaceuticals, Inc. (ARWR) vs Oscar Health, Inc. (OSCR)

A side-by-side comparison of Arrowhead Pharmaceuticals, Inc. and Oscar Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ARWR vs OSCR

growth of $100 · dividends reinvested · last 6y
ARWR -26.7% (-5.0%/yr)OSCR -6.8% (-1.2%/yr)OSCR compounded faster over this window
020406080100Start $10020222023202420252026$73$93
ARWR OSCR

ARWR vs OSCR: by the numbers

  • •ARWR is the larger company ($8.78B vs $8.41B market cap).
  • •OSCR is profitable (3.60% net margin) while ARWR runs a net loss (-47.79%).
  • •OSCR grew revenue faster over the past five years (64.83% vs 44.14% CAGR).

Metrics side by side

Valuation

MetricARWROSCR
P/E ratioN/A23.16
Forward P/EN/A16.98
P/S ratio13.120.55
P/B ratio18.874.10
EV / EBITDAN/A7.30
FCF yieldN/A51.57%

Profitability

MetricARWROSCR
Gross margin100.00%14.38%
Operating margin11.86%4.07%
Net margin-47.79%3.60%
ROE-68.73%26.84%
ROIC-12.12%22.98%

Growth (annualized)

MetricARWROSCR
Revenue CAGR (5Y)44.14%64.83%
FCF CAGR (5Y)N/A80.81%
Total return CAGR (5Y)0.75%14.97%

Frequently asked

Which has grown faster, ARWR or OSCR?
Over the past five years, OSCR grew revenue faster — ARWR at a 44.14% CAGR versus OSCR at 64.83%.
Is ARWR or OSCR more profitable?
OSCR runs the higher net margin — ARWR at -47.79% versus OSCR at 3.60%.
How have ARWR and OSCR total returns compared?
Over the past 5 years, ARWR delivered 0.75% and OSCR delivered 14.97% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.